dc.contributor.author | Zykova, Svetlana | |
dc.contributor.author | Balandina, K | |
dc.contributor.author | Vorokhobina, NV | |
dc.contributor.author | Kuznetsova, A | |
dc.contributor.author | Engstad, R | |
dc.contributor.author | Zykova, TA | |
dc.date.accessioned | 2015-03-11T07:15:55Z | |
dc.date.available | 2015-03-11T07:15:55Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | Journal of Diabetes Investigation 5(2014) nr. 4 s. 392-399 | en_US |
dc.identifier.cristinID | FRIDAID 1130805 | |
dc.identifier.doi | 10.1111/jdi.12165 | |
dc.identifier.issn | 2040-1116 | |
dc.identifier.uri | https://hdl.handle.net/10037/7391 | |
dc.identifier.urn | URN:NBN:no-uit_munin_6981 | |
dc.language.iso | eng | en_US |
dc.publisher | Wiley Open Access | en_US |
dc.rights.accessRights | openAccess | |
dc.subject | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Generell indremedisin: 770 | en_US |
dc.subject | VDP::Medical disciplines: 700::Clinical medical disciplines: 750::General internal medicine: 770 | en_US |
dc.title | Macrophage stimulating agent soluble yeast β-1,3/1,6-glucan as a topical treatment of diabetic foot and leg ulcers: A randomized, double blind, placebo-controlled phase II study | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |